Science Daily: Pharmacology News
APRIL 11, 2025
Astronomers are investigating the longest and most energetic bursts of X-rays seen from a newly awakened black hole. Watching this strange behavior unfold in real time offers a unique opportunity to learn more about these powerful events and the mysterious behavior of massive black holes.
Drugs.com
APRIL 11, 2025
FRIDAY, April 11, 2025 -- The U.S. Centers for Disease Control and Prevention (CDC) now recommends extra measles protection for people traveling to areas with active outbreaks in the United States, CBS News reported.In an April 8 letter, the CDC.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Science Daily: Pharmacology News
APRIL 11, 2025
A team of researchers reported the first direct observation of a surprising quantum phenomenon predicted over half a century ago known as a superradiant phase transition, which occurs when two groups of quantum particles begin to fluctuate in a coordinated, collective way without any external trigger, forming a new state of matter.
Drugs.com
APRIL 11, 2025
FRIDAY, April 11, 2025 -- How children respond to movement could provide an early means of detecting autism, a new study says.Children with autism are known to prefer watching repetitive movements over random movements, researchers said.Using.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Science Daily: Pharmacology News
APRIL 11, 2025
Using electrodes in a fluid form, researchers have developed a battery that can take any shape. This soft and conformable battery can be integrated into future technology in a completely new way.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Drugs.com
APRIL 11, 2025
FRIDAY, April 11, 2025 -- The U.S. Department of Health and Human Services (HHS) will launch a massive testing and research effort to explore the causes of autism, Secretary Robert F. Kennedy Jr. said Thursday.Kennedy, a longtime critic of vac.
New Drug Approvals
APRIL 11, 2025
Fitusiran 1711.0g/mol, C 78 H 139 N 11 O 30 FDA APPROVED 3/28/2025, Qfitlia , To prevent or reduce the frequency of bleeding episodes in hemophilia A or B Press Release CAS 1499251-18-1 EX-A12034 DA-53206 N-[1,3-Bis[3-[3-[5-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoylamino]propylamino]-3-oxopropoxy]-2-[[3-[3-[5-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoylamino]propylamino]-3-oxopropoxy]methyl]propan-2-yl]-12-[(2R,4R)-4
Science Daily: Pharmacology News
APRIL 11, 2025
In a striking demonstration of molecular control, a team of scientists has harnessed light to reverse the twist in self-assembling molecules. The study identifies how trace residual aggregates in photo-responsive azobenzene solutions can reverse helical chirality through secondary nucleation. By using precise control of ultraviolet and visible light, the researchers could switch between the rotation of helices, offering a breakthrough for novel materials with tunable properties.
Drugs.com
APRIL 11, 2025
FRIDAY, April 11, 2025 -- Spring is officially here, and with it comes watery eyes, stuffy noses and constant sneezing for people with seasonal allergies.And climate change means things are only going to get worse for allergy sufferers, a new.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Science Daily: Pharmacology News
APRIL 11, 2025
Pushing the limits of structured light, applied physicists report a new type of optical vortex beam that not only twists as it travels but also changes in different parts at different rates to create unique patterns. The way the light behaves resembles spiral shapes common in nature.
Drugs.com
APRIL 11, 2025
FRIDAY, April 11, 2025 -- The worlds first baby conceived through robot-controlled fertilization has been born, researchers say.The boy was born to a 40-year-old woman in Guadalajara, Mexico, following a previous in vitro fertilization (IVF) a.
BioPharma Drive: Drug Pricing
APRIL 11, 2025
The bispecific antibody helped people with small cell lung cancer live longer, Amgen said. Elsewhere, J&J shared new autoimmune drug data and Alzheon reported an Alzheimer’s drug failure.
Science Daily: Pharmacology News
APRIL 11, 2025
For the highly populated coastal country of Bangladesh, once-in-a-century storm tides could strike every 10 years -- or more often -- by the end of the century, scientists report.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drugs.com
APRIL 11, 2025
FRIDAY, April 11, 2025 -- Early symptoms of menopause will first appear when many women least expect them, a new Ohio State University poll reports.Hot flashes, mood swings, weight gain and insomnia are all symptoms of the hormone changes related.
Science Daily: Pharmacology News
APRIL 11, 2025
Earth's rocky layers are mysteriously low in nitrogen compared with carbon and argon. A scientific team explored our planet's molten youth using advanced quantum mechanical simulations, revealing nitrogen's secret: under extreme pressure, it chose to hide in the iron core 100 times more than the mantle. This solved why Earth's volatile ratios involving nitrogen look odd.
Drugs.com
APRIL 11, 2025
FRIDAY, April 11. 2025 -- Eviction bans implemented during the COVID-19 pandemic had an unexpected positive benefit for Americas children, a new study says.Reports of physical abuse, sexual abuse and child neglect all fell during U.S. eviction b.
Crown Bioscience
APRIL 11, 2025
From Undruggable to Druggable: The Shift in KRAS Research Historically, KRAS was a challenging target due to its smooth molecular surface and the high affinity of GTP binding, complicating the development of effective inhibitors. However, a pivotal breakthrough in 2013 utilizing innovative drug design strategies opened new avenues. This led to the development of the first successful KRAS inhibitors, which specifically target the G12C mutation prominent in non-small cell lung cancer and colorecta
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Alta Sciences
APRIL 11, 2025
Best Practices for Preclinical Dose Range Finding Studies pmjackson Fri, 04/11/2025 - 20:05 Dose range finding (DRF) studies are the foundation of preclinical drug development, providing crucial information on safety data to assist in the dose level selection before advancing into toxicology studies. These studies establish the minimum effective dose (MED) and maximum tolerated dose (MTD) to guide the design of subsequent studies while reducing unnecessary research animal use.
Drug Target Review
APRIL 11, 2025
Drug development is hampered by high costs, long timelines and a low probability of success and complex therapies exacerbate these challenges. While traditional artificial intelligence/machine learning (AI/ML) offers some benefits, generative AI, particularly when integrated with clinical genomics, presents a transformative opportunity. By integrating diverse data modalities, including clinical genomics , it can impact target identification, patient stratification and clinical trial design.
New Drug Approvals
APRIL 11, 2025
Tibremciclib cas 2397678-18-9, GTPL12881 CRB7BT5JDQ 518.6 g/mol, C 28 H 32 F 2 N 8 N -[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]-5-fluoro-4-[(1 R )-6-fluoro-1-methyl-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-8-yl]pyrimidin-2-amine Tibremciclib is a CDK4 inhibitor with antineoplastic activity [1]. Originator Betta Pharmaceuticals Co Ltd Class Antineoplastics; Small molecules Mechanism of Action Cyclin-dependent kinase 4 inhibitors; Cyclin-dependent kinase 6 inhibitors Phase III Breast canc
Drug Channels
APRIL 11, 2025
Todays guest post comes from Jim Hundemer, Chief Information Security Officer (CISO), and Sudhakar Velamoor, Chief Technology Officer (CTO), of Kalderos. Jim and Sudhakar discuss some of the complex challenges manufacturers face as they deal with outdated data systems, information silos, misapplied discounts, and growing cyber security threats. They argue that these challenges will lead to lost revenue, third-party security breaches, and diminished patient care.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
FDA Law Blog: Biosimilars
APRIL 11, 2025
By Andrew J. Hull Last month, we blogged on the Department of Justices (DOJ) abrupt announcement that it had determined that removal restrictions protecting administrative law judges (ALJs) were unconstitutional and that DOJ would no longer defend those removal restrictions in court. We opined that while the impact of this statement was unclear, it was likely that this position would make it more difficult for litigants challenging the constitutionality of a proceeding presided by an ALJ.
Broad Institute
APRIL 11, 2025
Variational inference for uncertainty quantification of microbial community dynamics By Lateisha Copeland-Guadarrama April 11, 2025 Variational inference for uncertainty quantification of microbial community dynamics Jaron Thompson University of Wisconsin-Madison, Venturelli Lab Variational inference is becoming a widely used approach that enables scalable approximations of intractable posterior distributions.
Drugs.com
APRIL 11, 2025
FRIDAY, April 11, 2025 President Donald Trump signed an order this week removing limits on how much water can come out of showerheads. He said the change will help Americans enjoy better showers and joked it would make Americas showers great aga.
Drugs.com
APRIL 11, 2025
FRIDAY, April 11, 2025 Nearly a half-million children could die from AIDS by 2030 if President Donald Trump follows through on plans to cut U.S. relief programs, a new study says.As many as 1 million additional children will become infected with H.
Expert insights. Personalized for you.
280 
Let's personalize your content